Drug intelligence / Profile preview

6-(3-aminophenyl)-N-tert-butyl-2-(trifluoromethyl)quinazolin-4-amine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the quinazolinamine class, with the molecular formula C19H19F3N4 and a molecular weight of approximately 360.38 g/mol[1][2][3]. It is primarily characterized as an experimental chemical probe or inhibitor targeting cyclin-dependent kinase 2 (CDK2), a key regulator of cell cycle progression. The compound has demonstrated inhibitory activity against CDK2, with an IC50 value of approximately 600 nM[1][2]. There are no known approved therapeutic indications or clinical uses for this molecule; it is mainly used in research settings to study cell cycle regulation and kinase inhibition.

Other names
6-(3-Aminophenyl)-N-tert-butyl-2-(trifluoromethyl)quinazolin-4-amineN-tert-butyl-2-(trifluoromethyl)-6-(3-aminophenyl)quinazoline-4-amine6-substituted quinazoline 51
02

Targets

CDK2 (Cyclin-dependent kinase 2)

Beyond the preview

Go deeper on 6-(3-aminophenyl)-N-tert-butyl-2-(trifluoromethyl)quinazolin-4-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-(3-aminophenyl)-N-tert-butyl-2-(trifluoromethyl)quinazolin-4-amine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call